Manganese butoxyethyl pyridyl porphyrin

N/A

Report date: 2023/11/21 14:22:35
NME

Base Information

Drug NameManganese butoxyethyl pyridyl porphyrin
Drug Alias NameBMX-001 free baseBMX-001MnTnBuOE-2-PyP5+
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor erythroid 2-related factor 2 stimulantsNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor erythroid 2-related factor 2Nuclear factor NF-kappa-B complex
Therapy Area/IndicationsBrain metastasesEndometrial NeoplasmsHead and Neck Neoplasms +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDuke University
China Registration ClassN/A

Develop Information

Active CompaniesBiomimetixDuke UniversityBiomimetix Jv Llc +[4] 
Inactive CompaniesN/A
Active IndicationsEndometrial NeoplasmsHead and Neck NeoplasmsOvarian Neoplasms +[8] 
Inactive IndicationsBrain metastases

Other Information

ATC CodeN/A
Related LinksN/A